Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-000094
Filing Date
2020-01-06
Accepted
2020-01-06 15:36:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 32058
2 filename2.txt TEXT-EXTRACT 1210
  Complete submission text file 0000000000-20-000094.txt   46126
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filed for) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances